Where to get Retatrutide

Where to get Retatrutide (LY3437943) is a new experimental medication for weight loss developed by Eli Lilly and Company. It works as a triple-hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors in the body. By acting on these receptors, the drug helps reduce appetite, increase fat burning, and support better metabolic health.

In Phase 2 clinical trials, people who received the highest dose (12 mg) lost an average of 24.2% of their body weight over 48 weeks. Every participant lost at least 5% of their body weight during the study. Researchers also observed improvements in blood pressure, blood sugar levels, and liver fat.

Retatrutide is taken as a once-weekly injection, which makes it convenient for many patients. Early results show a manageable side-effect profile when compared with other weight-loss treatments.

However, Retatrutide is still under clinical development and has not yet received regulatory approval for public use.